Participating in a clinical trial could mean getting cutting-edge therapies before they’re widely available—and we’re here to guide you.
Clinical trials aren’t “experimental” in the old sense. Today, they’re rigorous, highly-focused studies that match promising new drugs to the patients most likely to benefit.
Want to go deeper?
See our recent follow up video with more detailed clinical trial information.
Today’s approved therapies all began as investigational drugs, rigorously tested in clinical trials to prove their safety and effectiveness.
Phase 1 studies used to be guesswork, but now many focus on specific biomarkers or genetic targets, offering more precise and potentially more effective treatment.
Nearly every cancer trial offers at least the standard of care—so you’re never left with a placebo when real treatment is needed.
Physicians leading these studies are often top researchers with specialized experience—giving you a direct path to cutting-edge knowledge and therapies.
Clinical trials are carefully regulated studies that test whether new cancer treatments are safe and effective. Long before a drug is approved, it must demonstrate real promise in lab research and early human testing.
Researchers measure side effects, dosage tolerance, and overall effectiveness.
In the U.S., trials follow strict FDA and Institutional Review Board (IRB) guidelines to protect patient safety.
Newer trials often require specific biomarkers or genetic mutations, increasing the odds of success.
Now that you know the fundamentals, let’s explore when clinical trials could be the right choice for you.
Investors, scientists, and doctors aren’t testing random chemicals anymore—they invest millions in a drug only if there’s real promise behind it.
— Jason Sager, MD
We believe cancer patients should consider a clinical trial at each step. We find opportunities to access tomorrow’s standard of care—today.
Clinical trials can often be your best second-opinion resource—opening the door to innovative therapies.
If you’re dealing with a high-risk cancer, don’t rely on partial testing. A comprehensive series of diagnostic can steer you to better options ASAP.
Whenever your doctor suggests switching therapies, it’s worth exploring if a clinical trial could outperform current options.
Each time cancer returns or stops responding, new trials may offer fresh hope—especially if they target specific mutations.
Whenever you face a new decision point, we’ll match your situation to promising trials so you don’t miss an opportunity.
Our powerful technology and medical expertise let us filter through countless studies to focus on the few that truly match your cancer type, stage, and unique biomarkers.
Instead of navigating clinicaltrials.gov alone, we handle everything—from decoding medical jargon to organizing records and paperwork—so you can focus on your health.
Not all trials are equal. We connect you with leading specialists running each relevant study, ensuring you have access to their cutting-edge expertise.
Throughout your trial experience, we coordinate with oncologists, answer any questions, and help you explore your next steps as your situation evolves.
Clinical trials offer tomorrow’s treatments today. Let us take on the research so you don’t miss a life-changing opportunity.
Ready to take diagnostics a step further? Our service includes detailed record review, research, and 1-hour consultation with Dr. Sager.
Explore the services we provide with each consultation:
Contact us if you have questions not covered here.
Get started today—get professional, expert guidance toward the best available treatment, personalized for you.
